Multimodal AI applications in urologic oncology for prostate, bladder, and kidney cancers
Smarter Cancer Care: How AI Is Learning to See the Whole Picture
This narrative review examines multimodal artificial intelligence (AI) applications in urologic oncology for patients with prostate, bladder…
New AI tools combine scans, biopsies, and genes to give clearer answers for prostate, bladder, and kidney cancer patients, though most are s…
Izalontamab brengitecan shows activity in pretreated NSCLC with non-classical actionable genomic alterations
For lung cancer patients who have run out of options, a new drug mix shows promise but needs more time
This phase 1 study evaluated izalontamab brengitecan (iza-bren) in 83 patients with locally advanced or metastatic NSCLC harboring actionabl…
Lung cancer patients with limited options saw tumors shrink in 40% of cases and disease controlled in 86% using a new drug mix with manageab…
Phase 1b ABBV-368 combinations in recurrent/metastatic HNSCC show 14.3% overall response rate
Early study of ABBV-368 plus other drugs showed limited tumor response in head and neck cancer patients
This phase 1b, multicenter, open-label study enrolled 30 adults with recurrent or metastatic head and neck squamous cell carcinoma across th…
Early trials of ABBV-368 combined with other drugs showed limited tumor shrinkage in head and neck cancer patients despite a generally safe …
Aspirin and NSAIDs show little benefit for colorectal cancer prevention within 15 years but increase bleeding risk
The Aspirin-Cancer Question Has a Complicated Answer
This Cochrane meta-analysis of randomized controlled trials involving 124,837 participants evaluated aspirin and nonsteroidal anti-inflammat…
A major new review finds that taking daily aspirin to prevent colon cancer offers little benefit for the first 15 years while increasing ble…
Ultrasound features like size ≥10 mm and vascularity associate with neoplastic gallbladder polyps in meta-analysis
These Ultrasound Clues Could Signal a Dangerous Gallbladder Polyp
A systematic review and meta-analysis of 30 observational studies including 8,953 patients with gallbladder polyps found that ultrasound ima…
Eight specific ultrasound signs can help doctors spot dangerous gallbladder polyps early, guiding patients who need surgery sooner.
EHR-integrated symptom monitoring associates with reduced symptom prevalence and higher mortality risk in cancer patients
Chemo Side Effects Follow a Pattern — And It Could Save Lives
This secondary analysis of a cluster randomized clinical trial evaluated patients with gastrointestinal, thoracic, or gynecologic cancer ini…
Tracking fatigue, pain, and breathing trouble during chemotherapy helps predict which patients face the highest risk of death, allowing doct…
ML-driven decision aid reduces decisional conflict in prostate cancer screening discussions compared to standard education
How AI Helps Older Men Decide on Prostate Cancer Tests
This randomized controlled trial evaluated a web-based, machine learning-driven decision aid versus video-based education in middle-aged and…
A new digital tool helps older men make clearer choices about prostate cancer tests by reducing their worry and confusion.
Systematic review finds age and Galassi type influence pediatric middle fossa arachnoid cyst outcomes
Younger Kids Need More Watchful Eyes for Brain Cysts
A systematic review and meta-analysis of 1,024 pediatric patients with middle fossa arachnoid cysts examined associations with age and Galas…
Younger children with brain cysts are more likely to need repeat surgeries and shunts, highlighting the need for age-specific monitoring.
Minimally invasive surgical thermal ablation shows improved technical success and safety in liver malignancy patients
Minimally invasive surgery offers safe, effective treatment for liver cancer tumors
This systematic review and meta-analysis evaluated 3983 patients with hepatocellular carcinoma or colorectal liver metastases treated with m…
Minimally invasive surgery safely destroys liver cancer tumors with just 1% failure rate and 0.25% death risk for patients who can't have fu…
Simlukafusp alfa plus atezolizumab with or without bevacizumab shows antitumor activity in metastatic renal cell carcinoma
Does adding bevacizumab nearly triple the time before kidney cancer grows back?
A phase Ib randomized open-label study in 66 patients with metastatic renal cell carcinoma found objective response rates of 25% with simluk…
Adding bevacizumab nearly tripled the time before kidney cancer grew back compared to a two-drug mix in this early study.
Physical activity improves fatigue and muscle strength in pediatric cancer patients based on a meta-analysis of 24 studies
Does moving more help young cancer patients feel better and fight fatigue?
This systematic review and meta-analysis evaluated physical activity (PA) in children and adolescents with cancer across 24 studies.
Getting moving helps young cancer patients feel less fatigued, build stronger muscles, and improve their ability to think clearly and connec…
Pyridostigmine improves symptoms and reduces costs in adults with AChR MG in a crossover trial
The Pill Millions Take Daily Finally Gets Proof It Works
A randomized, double-blind, placebo-controlled crossover trial in 19 adults with anti-acetylcholine receptor-positive myasthenia gravis (ACh…
After decades of widespread use, a medication that helps people with myasthenia gravis regain muscle control now has its first rigorous clin…